{"id":"https://openalex.org/W2189147247","doi":null,"title":"PURPURA THROMBOPENIQUE, MYOSITE ET HEPATITE CYTOLYTIQUE : UNE ASSOCIATION RARE D'INCIDENTS LIES A L'ATORVASTATINE. Thrombocytopenia purpura, myositis and cytolitic hepatitis: a rare association of adverse events associated with atorvastatin.","display_name":"PURPURA THROMBOPENIQUE, MYOSITE ET HEPATITE CYTOLYTIQUE : UNE ASSOCIATION RARE D'INCIDENTS LIES A L'ATORVASTATINE. Thrombocytopenia purpura, myositis and cytolitic hepatitis: a rare association of adverse events associated with atorvastatin.","alternate_titles":[],"publication_year":2013,"publication_date":"2013-01-01","ids":{"openalex":"https://openalex.org/W2189147247","mag":"2189147247"},"language":"fr","primary_location":{"id":"mag:2189147247","doi":null,"is_oa":false,"landing_page_url":"http://malimedical.org/2013/49a.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W2189147247"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108542142","display_name":"Papa Souleymane Tour\u00e9","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Papa Souleymane Tour\u00e9","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110136083","display_name":"Yakham Mohamed L\u00e9ye","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yakham Mohamed L\u00e9ye","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076180243","display_name":"M Diop","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M Diop","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013431818","display_name":"Ablaye Leye","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ablaye Leye","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036518267","display_name":"Souleymane Tour\u00e9","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Souleymane Tour\u00e9","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012880655","display_name":"Yakham Mohamed","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yakham Mohamed","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038811606","display_name":"Madoky Maguette","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Madoky Maguette","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076180243","display_name":"M Diop","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M Diop","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029012530","display_name":"Mamadou Mourtalla","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mamadou Mourtalla","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5108127387","display_name":"Ka","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ka","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.7372999787330627,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.7372999787330627,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.13339999318122864,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.08640000224113464,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atorvastatin","display_name":"atorvastatin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/statin-adverse-effects","display_name":"statin adverse effects","score":0.7749999761581421},{"id":"https://openalex.org/keywords/drug-induced-thrombocytopenia","display_name":"drug-induced thrombocytopenia","score":0.9580000042915344},{"id":"https://openalex.org/keywords/purpura","display_name":"purpura","score":0.7450000047683716},{"id":"https://openalex.org/keywords/inflammatory-myopathies","display_name":"myositis","score":0.9290000200271606},{"id":"https://openalex.org/keywords/rhabdomyolysis","display_name":"rhabdomyolysis","score":0.906000018119812},{"id":"https://openalex.org/keywords/cytolytic-hepatitis","display_name":"cytolytic hepatitis","score":0.7419999837875366},{"id":"https://openalex.org/keywords/drug-induced-liver-injury","display_name":"drug-induced liver injury","score":0.6940000057220459},{"id":"https://openalex.org/keywords/hypercholesterolemia","display_name":"hypercholesterolemia","score":0.8859999775886536},{"id":"https://openalex.org/keywords/drug-induced-myopathy","display_name":"drug-induced myopathy","score":0.4830000102519989}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8503330945968628},{"id":"https://openalex.org/C2781232998","wikidata":"https://www.wikidata.org/wiki/Q1433212","display_name":"Myositis","level":2,"score":0.8101043701171875},{"id":"https://openalex.org/C2778616394","wikidata":"https://www.wikidata.org/wiki/Q474959","display_name":"myalgia","level":2,"score":0.7935183048248291},{"id":"https://openalex.org/C2777482532","wikidata":"https://www.wikidata.org/wiki/Q668093","display_name":"Atorvastatin","level":2,"score":0.7811330556869507},{"id":"https://openalex.org/C2777121669","wikidata":"https://www.wikidata.org/wiki/Q148881","display_name":"Purpura (gastropod)","level":2,"score":0.6329690217971802},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.47140124440193176},{"id":"https://openalex.org/C2776029263","wikidata":"https://www.wikidata.org/wiki/Q131742","display_name":"Hepatitis","level":2,"score":0.4613495171070099},{"id":"https://openalex.org/C2779379848","wikidata":"https://www.wikidata.org/wiki/Q917069","display_name":"Rhabdomyolysis","level":2,"score":0.44203096628189087},{"id":"https://openalex.org/C2776455275","wikidata":"https://www.wikidata.org/wiki/Q154869","display_name":"Hepatitis C","level":2,"score":0.42907166481018066},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.39513668417930603},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3399626612663269},{"id":"https://openalex.org/C18903297","wikidata":"https://www.wikidata.org/wiki/Q7150","display_name":"Ecology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2189147247","doi":null,"is_oa":false,"landing_page_url":"http://malimedical.org/2013/49a.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":7,"referenced_works":["https://openalex.org/W1970189800","https://openalex.org/W1981601094","https://openalex.org/W2015185078","https://openalex.org/W2021372314","https://openalex.org/W2048859524","https://openalex.org/W2132578256","https://openalex.org/W2341497648"],"related_works":["https://openalex.org/W2155257230","https://openalex.org/W2734436972","https://openalex.org/W40896153","https://openalex.org/W2148925523","https://openalex.org/W4396748720","https://openalex.org/W1970189800","https://openalex.org/W2012009927","https://openalex.org/W2988316132","https://openalex.org/W3129139959","https://openalex.org/W2022264230"],"abstract_inverted_index":{"Statins":[0],"are":[1],"generally":[2],"well":[3],"tolerated":[4],"drugs.":[5],"Potentially":[6],"life-threatening":[7],"adverse":[8],"events":[9],"can":[10],"occur.":[11],"We":[12],"report":[13],"a":[14,17,68],"case":[15],"of":[16,33,42,64,85,90,94,101],"70-year-old":[18],"woman":[19],"with":[20,24,46],"high":[21],"blood":[22],"pressure":[23],"hypercholesterolemia":[25],"treated":[26],"by":[27],"atorvastatin.":[28],"Two":[29],"weeks":[30],"after":[31],"introduction":[32],"this":[34,86],"new":[35],"drug":[36],"the":[37,75,83,99],"patient":[38],"developed":[39],"muscular":[40],"weakness":[41],"all":[43],"four":[44],"limbs":[45,51],"myalgia,":[47],"purpura":[48],"and":[49,52,59],"upper":[50],"abdomen.":[53],"Biology":[54],"revealed":[55],"severe":[56],"thrombocytopenia,":[57],"myolysis":[58],"cytolytic":[60],"hepatitis.":[61],"The":[62,79,88],"cessation":[63],"atorvastatin":[65],"resulted":[66],"in":[67,70,98],"favorable":[69],"twenty":[71],"days.":[72],"This":[73],"suggests":[74],"drug-induced":[76],"abnormalities":[77],"found.":[78],"literature":[80],"data":[81],"confirm":[82],"rarity":[84],"association.":[87],"severity":[89],"some":[91],"side":[92,109],"effects":[93],"statins":[95],"should":[96],"remain":[97],"minds":[100],"prescribers.":[102],"Keywords":[103],":":[104],"atorvastatin,":[105],"purpura,":[106],"myositis,":[107],"cytolysis,":[108],"effects.":[110]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2189147247","counts_by_year":[],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2016-06-24T00:00:00"}
